Purification of recombinant pp60v-src protein tyrosine kinase and phosphorylation of peptides with different secondary structure preference.

Biochemistry
C RadziejewskiE T Kaiser

Abstract

The expression of the transforming gene product of Rous sarcoma virus (pp60v-src) in Saccharomyces cerevisiae has recently been reported (Kornbluth et al., 1987; Brugge et al., 1987). To carry out biochemical and structural studies of this enzyme, a facile purification was developed. The purification was accomplished in four chromatographic steps: Q-Sepharose, Affi-Gel Blue, phosphoagarose, and hydroxylapatite chromatography. The tyrosine kinase was isolated in milligram quantities as two highly active proteolytic fragments (52 and 54 kDa). Three model tyrosine kinase substrates with propensities to adopt helical or omega-loop conformations were synthesized and characterized. The peptides were based on the sites of phosphorylation of pp60v-src, lipocortin I, and lipocortin II. Circular dichroism spectroscopy was used to study the conformation of the helix-forming peptides in 50 mM Tris and in 50% trifluoroethanol/Tris. Peptide 1, which was designed to form an amphiphilic alpha-helix, displayed 24.2% helicity in buffer and 40.2% helicity in 50% TFE/buffer. Similar experiments for peptide 3, the other helix former, showed a lower helicity (8.1% helical and 26.0% helical in buffer and in 50% TFE/buffer, respectively). All three pe...Continue Reading

References

Jan 1, 1978·Annual Review of Biochemistry·P Y Chou, G D Fasman
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J R Glenney, B F Tack
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S KornbluthH Hanafusa
Jan 1, 1987·Annual Review of Cell Biology·R Jove, H Hanafusa
Jan 1, 1985·Annual Review of Biochemistry·T Hunter, J A Cooper
May 1, 1986·Nature·R B Pepinsky, L K Sinclair
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R HirstL Rohrschneider
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W T Miller, E T Kaiser
Nov 14, 1986·Science·J F Leszczynski, G D Rose
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·S A CourtneidgeJ M Bishop
Jan 20, 1984·Science·E T Kaiser, F J Kézdy
Mar 3, 1981·Biochemistry·J P Hennessey, W C Johnson

❮ Previous
Next ❯

Citations

Oct 1, 1994·The International Journal of Biochemistry·J A Boutin
Dec 1, 1993·Journal of Dermatological Science·B C BastianE B Bröcker
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S E ShoelsonM F White
Jan 1, 1997·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·R L Brockbank, H J Vogel
Apr 22, 1993·International Journal of Cancer. Journal International Du Cancer·J D CroxtallR J Flower
Sep 20, 1996·Journal of Chromatography. B, Biomedical Applications·J A Boutin
Oct 30, 1992·Biochemical and Biophysical Research Communications·D B SacksJ M McDonald
Dec 6, 2005·Protein Expression and Purification·Duane P JeansonneJoseph A Vaccaro
May 15, 1991·Biochemical and Biophysical Research Communications·H J Goren, D Boland
Jul 27, 2000·Molecular and Cellular Biology·M R BurnhamA H Bouton
Oct 28, 1992·Annals of the New York Academy of Sciences·S FerrariU Torelli
Jan 15, 2015·Molecular & Cellular Proteomics : MCP·Lily L JinMichael F Moran
Sep 1, 1993·International Journal of Peptide and Protein Research·J S McMurrayD F Dyckes
Feb 1, 1994·International Journal of Peptide and Protein Research·N U ObeyesekereJ S McMurray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.